247 related articles for article (PubMed ID: 16039577)
21. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
22. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
23. Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects.
Wambre E; Van Overtvelt L; Maillère B; Humphreys R; von Hofe E; Ferhat L; Ebo D; Moingeon P
Int Arch Allergy Immunol; 2008; 146(2):99-112. PubMed ID: 18204276
[TBL] [Abstract][Full Text] [Related]
24. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
25. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior.
Chaves FA; Richards KA; Torelli A; Wedekind J; Sant AJ
Biochemistry; 2006 May; 45(20):6426-33. PubMed ID: 16700553
[TBL] [Abstract][Full Text] [Related]
26. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
27. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
28. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
[TBL] [Abstract][Full Text] [Related]
29. Regulation of peptide presentation by major histocompatibility complex class II molecules at the surface of macrophages.
von Delwig A; Musson JA; McKie N; Gray J; Robinson JH
Eur J Immunol; 2003 Dec; 33(12):3359-66. PubMed ID: 14635044
[TBL] [Abstract][Full Text] [Related]
30. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
[TBL] [Abstract][Full Text] [Related]
31. Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules.
Latek RR; Petzold SJ; Unanue ER
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11460-5. PubMed ID: 11016975
[TBL] [Abstract][Full Text] [Related]
32. Understanding the focused CD4 T cell response to antigen and pathogenic organisms.
Weaver JM; Sant AJ
Immunol Res; 2009 Dec; 45(2-3):123-43. PubMed ID: 19198764
[TBL] [Abstract][Full Text] [Related]
33. New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.
Haque A; Blum JS
J Biol Regul Homeost Agents; 2005; 19(3-4):93-104. PubMed ID: 16602623
[TBL] [Abstract][Full Text] [Related]
34. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
35. The wide diversity and complexity of peptides bound to class II MHC molecules.
Suri A; Lovitch SB; Unanue ER
Curr Opin Immunol; 2006 Feb; 18(1):70-7. PubMed ID: 16316750
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the role of determinant selection in genetic control of the immune response to insulin in H-2b mice.
Thayer WP; Kraft JR; Tompkins SM; Moore JC; Jensen PE
J Immunol; 1999 Sep; 163(5):2549-54. PubMed ID: 10452992
[TBL] [Abstract][Full Text] [Related]
40. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
